EULAR 2021

Update GRAPPA recommendations & axial PsA vs axSpA

Treatment decissions and therapeutic options in PsA

RA treatment - status and perspectives

Early detection and treatment of RA

Difficult to treat RA - hot topics and challenges

JAKi in real life!

Vitamin D level in response to biologics

RA activity and risk of complications after…

Recurrence of joint inflammation

Using anti-TNF to deliver corticosteroids to…

Clinical outcome after switching between IL-6 and JAK…

Interstitial lung disease in patients with RA

Risk of cardiovascular events and disease activity

Influence of comorbitidy on mortality

Passive smoking in childhood and adulthood increases…

Definition of difficult to treat rheumatoid arthritis

Vitamine D et réponse aux biomédicaments

Complications après arthroplastie selon l’activité du…

Où les arthrites récidivent-elles?

Interstitiell lungesykdom hos pasienter med RA

Risiko for kardiovaskulære hendelser og…

Påvirkning av komorbiditeter på mortalitet

El tabaquismo pasivo aumenta el riesgo de padecer una…

Definición de artritis reumatoide difícil de tratar

Deucravacitinib (TYK2 Inhibitor) in Psoriasis and…

Secukinumab: Adherence in PsA and AS

Hyperuricemia: increased risk of severe PsA course

Power-Doppler ultrasound of the achilles tendon to…

GRAPPA Recommendations 2021

Faeceal microbiota transplantation

Role of Sex and Weight on PsA

Deucravacitinib (TYK 2 Inhibitor) neu bei PsA und…

Secukinumab: Adhärenz bei PsA and AS

Cave Hyperurikämie: Erhöhtes Risiko für schweren…

Power-Doppler-Sono AS: Differenzierung Belastung vs.…

GRAPPA Empfehlungen 2021

Rolle von Geschlecht und Gewicht

Impact of sex on BASDAI scores

Radiographic progression in axSpA

Feasibilty of anti-TNF tapering in low disease…

Non-radiographic or radiographic axial SpA - does it…

fattibilità della riduzione del dosaggio degli anti-TNF…

¿Nos ayudan los pacientes con espondiloartritis axial?

Progresión radiográfica en espondiloartritis axial

Influence of TNF-Inhibition on COVID-19

COVID-19 outcome in inflammatory arthropathy patients

Rituximab and COVID-19 (Multicenter-Study)

Rituximab and COVID-19 (Nat. French Registry Study)

Outcome of Covid-19 in Rheumatoid Arthritis under…

Risk factors of COVID-19 course in SLE

COVID-19 Vaccination in patients with rheumatic disease

Patientenumfrage während der Pandemie

COVID-19 bei SLE

Rituximab bei COVID-19 (franz. Registerdaten)

Rituximab bei COVID-19 (Multicenter-Studien)

Einfluss von TNF-Blockern auf COVID-19-Verlauf

SARS-CoV2-Impfung bei Rheumapatienten

Convincing Anifrolumab data on efficacy and drug…

Combination of Belimumab and Rituximab is beneficial

Anifrolumab in Wirksamkeit und Verträglichkeit…

Neue Therapie für kutane Manifestationen

Ultrasound halo sign as a potential monitoring tool for…

Tocilizumab Monotherapy for Giant Cell Arteritis - the…

What is new in Giant Cell Arteritis?

Efficacia e sicurezza degli anti-TNF e del tocilizumab…

Secukinumab in patients with rotator cuff tendinopathy

Therapeutic drug monitoring and immunogenicity

Fatigue in Arthritis, SpA & systemic rheumatic diseases

Risk factors for ADAb formation: Data from the NOR-DRUM…

EULAR, najnowsze postępy w reumatologii

Therapeutic drug monitoring (TDM) og immunogenisitet

Co nowego w reumatologii dziecięcej